(Q57200902)

2

0 references

Miguel López-Botet

object named as

Miguel López-Botet

7

0 references

author name string

Adriana Monsiváis-Urenda

1

0 references

Alba Hernández-Salinas

3

0 references

Christian García-Sepúlveda

4

0 references

Neus Romo

5

0 references

Lourdes Baranda

6

0 references

Roberto González-Amaro

European Journal of Immunology

8

0 references

language of work or name

English

0 references

publication date

3 March 2010

0 references

published in

0 references

volume

40

0 references

issue

5

0 references

page(s)

1418-1427

0 references

cites work

Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Regulation of natural killer cell activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Human NK-cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

MHC class I molecules and KIRs in human history, health and survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

The LILR family: modulators of innate and adaptive immune pathways in health and disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

A multigene family on human chromosome 12 encodes natural killer-cell lectins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Association of DAP12 with activating CD94/NKG2C NK cell receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Host immune system gene targeting by a viral miRNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

The Contribution of Cytomegalovirus to Changes in NK Cell Receptor Expression in HIV‐1–Infected Individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Congenital cytomegalovirus infection in San Luis Potosi, Mexico

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Asymptomatic primary cytomegalovirus infection: virologic and immunologic features

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Human NK cells can control CMV infection in the absence of T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

The expression of human natural killer cell receptors in early life

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021

Comparison of prokaryotic diversity at offshore oceanic locations reveals a different microbiota in the Mediterranean Sea

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939898

7 January 2021